EUVIMEDEUVIMED entdecken
Open Access

Atractylenolide II combined with Interferon-γ synergistically ameliorates colorectal cancer progression in vivo and in vitro by blocking the NF-kB p65/PD-L1 pathway

Yangsheng Wu, Shijie Dai, YuJia Zhang, Zheming Li, Bo Zhu, Qingsheng Liu, Like Wo, Zhiling Yu, Xiaofeng Yuan, Xiaobing Dou

Journal of Cancer · 2024 · 15 (13) · 4328-4344

DOI: 10.7150/jca.96647 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer, 2024. Verfasst von Yangsheng Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Atractylenolide IIColorectal cancerInterferon-γPD-L1.

Autor:innen und Institutionen

  • College of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • College of pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Hangzhou Traditional Chinese Medicine Hospital, Hangzhou, Zhejiang, China.
  • The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
  • Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

Zitieren

APA

Wu, Y., Dai, S., Zhang, Y., Li, Z., Zhu, B., Liu, Q., Wo, L., Yu, Z., Yuan, X., & Dou, X. (2024). Atractylenolide II combined with Interferon-γ synergistically ameliorates colorectal cancer progression in vivo and in vitro by blocking the NF-kB p65/PD-L1 pathway. Journal of Cancer, 15(13), 4328-4344. https://doi.org/10.7150/jca.96647

Vancouver

Wu Y, Dai S, Zhang Y, Li Z, Zhu B, Liu Q, et al. Atractylenolide II combined with Interferon-γ synergistically ameliorates colorectal cancer progression in vivo and in vitro by blocking the NF-kB p65/PD-L1 pathway. Journal of Cancer. 2024;15(13):4328-4344. doi:10.7150/jca.96647

BibTeX
@article{Wu2024,
  author = {Wu, Yangsheng and Dai, Shijie and Zhang, YuJia and Li, Zheming and Zhu, Bo and Liu, Qingsheng and Wo, Like and Yu, Zhiling and Yuan, Xiaofeng and Dou, Xiaobing},
  title = {Atractylenolide II combined with Interferon-γ synergistically ameliorates colorectal cancer progression in vivo and in vitro by blocking the NF-kB p65/PD-L1 pathway},
  journal = {Journal of Cancer},
  year = {2024},
  volume = {15},
  number = {13},
  pages = {4328--4344},
  doi = {10.7150/jca.96647}
}
Kostenlos starten →